|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization | |||
| Amortization of right-of-use assets | |||
| Amortization of contract costs to obtain | |||
| Amortization of contract costs to fulfill | |||
| Amortization of deferred financing fees | |||
| Stock-based compensation | |||
| Deferred income taxes | |||
| Bad debt expense | |||
| Gain on derecognition of right-of-use asset and lease liabilities | |||
| Foreign currency loss (gain) | |||
| Investments interest receivable, amortization and accretion | |||
| Loss on debt extinguishment | |||
| Bargain purchase gain | |||
| Loss on divestiture | |||
| Loss on disposal of property, equipment and software | |||
| Change in fair value of derivative, warrant, and contingent consideration liabilities | |||
| Warrant expense | |||
| Issuance of common stock or warrants for services | |||
| Change in fair value of derivative liability and contingent consideration | |||
| Noncash interest expense | |||
| Paid-in-kind interest capitalized | |||
| Income from equity method investment | |||
| Changes in operating assets and liabilities: | |||
| Accounts receivable | |||
| Prepaid expenses and other current assets | |||
| Other assets | |||
| Accounts payable | |||
| Accrued expenses | |||
| Deferred revenue | |||
| Lease liabilities | |||
| Long-term liabilities | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities: | |||
| Purchases of property, equipment and software | |||
| Investment in capitalized software | |||
| Proceeds from sale of marketable securities | |||
| Divested cash | |||
| Cash acquired from the Otonomo merger | |||
| Net cash provided by (used in) investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from issuance of long-term debt, net of discount | |||
| Repayment of long-term debt | |||
| Payments of deferred financing fees | |||
| Refunds (payments) of deferred financing fees | |||
| Proceeds from issuance of convertible notes payable | |||
| Proceeds from revolving credit facility | |||
| Payments on revolving credit facility | |||
| Proceeds from issuance of common stock, net | |||
| Net cash provided by (used in) financing activities | |||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||
| Net decrease in cash, cash equivalents and restricted cash | |||
| Cash, cash equivalents and restricted cash, beginning of year | |||
| Cash, cash equivalents and restricted cash, end of year | |||
| Supplemental disclosure of cash flow information: | |||
| Cash paid for interest | |||
| Cash paid for income taxes | |||
| Supplemental noncash investing and financing activities: | |||
| Common stock consideration for Otonomo merger | |||
| Net assets acquired from the Otonomo merger, excluding cash | |||
| Conversion of convertibles notes to common stock | |||
| Conversion of warrants to common stock | |||
| Derivative liability resulting from term loan amendment | |||
| Derivative liability resulting from issuance of convertible notes | |||
| Issuance of common stock for services | |||
| Issuance of common stock in connection with term loan amendment |
Loading...